Top Videos
Top Searches
Moods & Genres
Autumn
Chill
Commute
Energize
Feel-good
Focus
Gaming
Party
Romance
Sad
Sleep
Summer
Winter
Workout
African
Arabic
Blues
Bollywood & Indian
Classical
Country and Americana
Dance and electronic
Decades
Family
Folk and acoustic
German hip-hop
German pop
Hip-hop
Indie and alternative
J-Pop
Jazz
K-Pop
Latin
Mandopop & Cantopop
Metal
Pop
R&B and soul
Reggae and caribbean
Rock
Schlager
Soundtracks and musicals
Search music and videos
CaDAnCe-101 trial: exploring the potential of tacabrutideg, a novel BTK degrader, in R/R CLL/SLL
Duration unavailable
|
Views unavailable
|
Download MP3
Related Videos
Future perspectives in frontline MCL treatment and management: a European and US view
Current role of AI in hematology/oncology: separating the hype from reality
Kenneth Anderson: What are the next steps to a myeloma cure?
Proposed updates to the classification of MDS, MDS/MPNs, and MPNs
Sequencing pirtobrutinib in CLL: overcoming covalent BTKi resistance and future first-line use
Essential genomic tests and patient-centered treatment decisions in CLL
Unmet needs in Waldenström’s macroglobulinemia
Predicting and monitoring CAR T-cell toxicities in multiple myeloma
Anti-BCMA CAR T-cell therapy in CNS-involved myeloma: safety and long-term outcomes
Current role of autoSCT and chemotherapy-free approaches in frontline MCL
Unmet needs in CLL genomics: heterogeneity and clinical impact
Assessing treatment responses and long-term outcomes in CLL
Welcome to the Video Journal of Hematology & Hematological Oncology 🎥🩸
New clinical trial results in cardiac and peripheral nerve amyloidosis
How have the BMT CTN myeloma trials impacted clinical practice?
Venetoclax combination therapies in AML
Update from DART4MM: daratumumab consolidation after ASCT in patients with multiple myeloma
Personalizing care in R/R follicular lymphoma: selecting patients for novel combination therapies
Exploring the concept of functional cure in CLL
Biomarker-guided treatment selection in frontline CLL: the role of IGHV and TP53 status
